Can Men with Oligospermia in Georgia Undergo IVF? ICSI Procedure and Conditions Explained

Consultation Scenario: An Oligospermia Patient Inquires About IVF Feasibility in Georgia

A 35-year-old male provided a semen analysis report during a remote consultation: sperm concentration 7.8 million/ml, total motility 42%, normal morphology 3%. He asked whether IVF was possible in Georgia under these conditions and what specific preparations were needed. This article provides a systematic response to such questions based on clinical reproductive medicine pathways.

Direct Answer: Men with Oligospermia in Georgia Can Undergo IVF; the Core Technology is ICSI

Reproductive centers in Georgia are generally equipped with Intracytoplasmic Sperm Injection (ICSI) technology, which is the standard method for treating oligospermia. ICSI involves an embryologist selecting morphologically normal sperm under a microscope and injecting it directly into the oocyte cytoplasm to achieve fertilization, bypassing the natural fertilization barriers caused by low sperm concentration and motility. Therefore, as long as viable sperm are present in the testicles, patients with oligospermia can achieve fertilization and embryo culture through ICSI.

Conditions for Applying ICSI in Oligospermia

• When sperm concentration is ≥0.1 million/ml, sufficient sperm can usually be obtained from ejaculated semen for ICSI.
• When concentration is below 0.1 million/ml, Testicular Sperm Aspiration (TESA) or Microdissection Testicular Sperm Extraction (Micro-TESE) may be required.
• Reproductive laboratories in Georgia have mature experience handling very low sperm concentrations, including density gradient centrifugation and specialized selection techniques.

Core Evaluation Dimensions for Oligospermia IVF by Reproductive Specialists

From a clinical decision-making perspective, doctors do not rely solely on sperm concentration to determine IVF feasibility. The following three dimensions are equally important:

• Sperm DNA Fragmentation Index (DFI): When DFI exceeds 30%, even if ICSI fertilization is successful, the risk of embryo arrest and miscarriage increases. Some reproductive centers in Georgia include DFI as a routine test.
• Chromosomal Karyotype Analysis: The incidence of Y-chromosome microdeletions in oligospermia patients is approximately 8-12%. This test result directly impacts sperm retrieval strategy and genetic counseling.
• Testicular Reserve Function Assessment: Evaluating overall spermatogenic function through Inhibin B, FSH levels, and testicular ultrasound. When FSH is more than twice the upper normal limit, the success rate of testicular sperm aspiration decreases significantly.

When is it Appropriate to Proceed Directly with an IVF Cycle?

When an oligospermia patient meets all the following conditions, reproductive centers in Georgia typically recommend proceeding directly with an ICSI cycle:

• Female partner age ≤40 years, AMH ≥1.2 ng/ml, antral follicle count ≥6
• At least a small number of morphologically normal sperm can be detected in the male's ejaculate
• Both partners have normal chromosomal karyotypes
• No uncontrolled reproductive tract infections

When are Additional Tests or Treatments Needed First?

• DFI>30%: Antioxidant therapy (Coenzyme Q10, Zinc, Vitamin E, etc.) is recommended for 2-3 months before re-evaluation.
• Y-chromosome microdeletion: Sperm retrieval method depends on the type of deletion; some types only allow use of testicular sperm.
• Suspected obstructive oligospermia: Tests such as seminal plasma biochemistry and transrectal ultrasound are needed to identify the obstruction site.

Differences in Oligospermia IVF Across Countries

The differences between Georgia and other countries regarding oligospermia IVF are mainly in three aspects:

• Legal Environment: Georgia allows the use of donor sperm as a backup option. If the patient cannot obtain sufficient sperm, donor sperm ICSI is an option. Some countries have stricter regulations on this.
• Laboratory Standards: Top-tier reproductive centers in Georgia are equipped with laser-assisted hatching and time-lapse embryo culture systems, which aid in embryo selection for oligospermia patients.
• Cost Structure: The cost of an ICSI cycle in Georgia is approximately 40-50% of that in Western European countries, but embryo freezing and storage fees are calculated separately. Oligospermia patients usually need to pay extra for TESA or Micro-TESE procedures.

Easily Overlooked Details: Preparation Before Oligospermia IVF

In clinical consultations, the following details are often overlooked by patients but have a direct impact on cycle outcomes:

• Sperm Cryopreservation: It is recommended to freeze at least 2-3 semen samples before the female partner starts ovarian stimulation. Sperm quality in oligospermia patients can fluctuate; freezing in advance mitigates the risk of having no sperm available on the day of egg retrieval.
• Reproductive Tract Infection Screening: Infections with Ureaplasma urealyticum, Chlamydia trachomatis, and Neisseria gonorrhoeae can cause sperm DNA damage and reduced fertilization rates. Reproductive centers in Georgia require infection screening reports valid for 3 months.
• Medication Effects: Some antibiotics, antidepressants, and hormonal drugs can reversibly affect spermatogenesis. Patients must inform their doctor of all medications taken in the past 3 months.
• Abstinence Period Control: For oligospermia patients, an abstinence period of 2-3 days is recommended, not exceeding 5 days. Prolonged abstinence can increase sperm DNA fragmentation, potentially reducing ICSI success.

Actual Procedure: Steps from Initial Consultation to Embryo Transfer

The basic process for oligospermia IVF in Georgia is divided into the following stages:

Stage 1: Preparation at Home (1-2 months)

• Both partners complete chromosomal karyotype analysis, infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis), blood type, and coagulation function tests.
• Male partner completes semen analysis (at least 2 times, 2 weeks apart), DFI test, and Y-chromosome microdeletion test.
• Female partner completes AMH, FSH, LH, thyroid function, and hysteroscopy.
• Prepare passports, notarized marriage certificate, and translated copies of medical records.

Stage 2: Initial Visit to Georgia (3-5 days)

• In-person consultation with a reproductive specialist to review all test reports and confirm the ICSI plan.
• Sign informed consent forms, including ICSI procedure explanation, embryo freezing agreement, and disclosure of multiple pregnancy reduction risks.
• If necessary, arrange Testicular Sperm Aspiration (TESA) and cryopreservation.

Stage 3: Ovarian Stimulation and Egg Retrieval (12-16 days)

• Female partner uses ovarian stimulation medications with regular monitoring of follicle development.
• On the day of egg retrieval, the male partner provides a semen sample or frozen sperm is thawed.
• Embryologist performs ICSI and records fertilization results.

Stage 4: Embryo Culture and Transfer (5-7 days)

• Embryos are cultured to day 5-6 for blastocyst morphological grading.
• If conditions permit, PGT-A (Preimplantation Genetic Testing for Aneuploidy) is performed.
• Select 1-2 high-quality blastocysts for transfer; remaining embryos are cryopreserved.

Test Result Interpretation: Core Items Related to Oligospermia

Special Situations: Cryptozoospermia and Azoospermia

A special condition within oligospermia is cryptozoospermia, where no sperm are found in a routine semen analysis, but a very small number can be observed in the centrifuged pellet. These patients can also complete IVF via ICSI, but the timing of sperm retrieval and sample processing require higher precision. Embryologists in Georgia typically employ the following strategies:

• Multiple ejaculations on the day of egg retrieval, with careful screening after each centrifugation.
• Using specialized culture media and micromanipulation techniques to select sperm from the pellet.
• If no sperm are obtained on the day of egg retrieval, a backup plan—testicular sperm aspiration—is initiated.

For patients with complete azoospermia, it is first necessary to confirm the presence of sperm foci through testicular biopsy or microdissection. Approximately 50% of patients with non-obstructive azoospermia can obtain sperm via Micro-TESE. If no sperm are found, donor sperm must be used. Georgian law permits the use of donor sperm from legitimate sperm banks, with donor information managed anonymously or semi-anonymously.

Frequently Asked Questions

Is the success rate of IVF in Georgia guaranteed for oligospermia patients?

This is a question that needs to be discussed on a case-by-case basis. The fertilization rate with ICSI is typically between 70-85% and is not directly linearly related to sperm concentration. However, the final pregnancy outcome is influenced by multiple factors including female age, embryo chromosomal ploidy, and endometrial receptivity. Considering only the male factor, as long as a sufficient number of viable sperm are obtained for ICSI, the fertilization rate for oligospermia patients is not significantly different from those with normal semen parameters.

How far in advance should one arrive in Georgia?

It is recommended that the female partner arrives 3-5 days before starting ovarian stimulation for the initial consultation and record setup. The male partner can arrive 2-3 days before the egg retrieval day. However, if testicular biopsy is needed, arriving 5-7 days in advance is recommended to arrange the surgery and allow for post-operative recovery.

If one ICSI cycle fails, how many times can it be repeated?

Reproductive centers in Georgia generally do not have a strict limit on the number of cycles, but it is recommended to have an interval of at least 3 months between cycles to adjust the stimulation protocol and improve sperm quality. After two consecutive ICSI failures, it is advisable to re-evaluate sperm DNA fragmentation index, chromosomal karyotype, and embryo chromosomal ploidy.

What should oligospermia patients pay attention to during IVF in Georgia?

• Choose a reproductive center with an independent embryology laboratory and full-time embryologists.
• Confirm that the center has the surgical capability for TESA/Micro-TESE.
• Understand the fee structure for embryo freezing and storage in advance.
• Prepare complete reports for semen analysis, DFI, and chromosomal karyotype.

Doctor's Advice: Three Questions to Clarify Before Making a Decision

• Is the sperm source sufficient? If the sperm concentration in ejaculate is extremely low (<0.1 million/ml), it is advisable to first perform a testicular biopsy to assess spermatogenic function and confirm sufficient sperm reserves before starting a cycle.
• Is the female partner's fertility within the optimal window? Female age is the most important factor affecting ICSI outcomes. If the female partner is ≥38 years old, prioritizing embryo chromosomal screening (PGT-A) is recommended to reduce the risk of miscarriage.
• Does the budget cover backup options? If the patient's own sperm cannot be used, a donor sperm plan needs to be activated. The cost of donor sperm in Georgia is approximately €1,200-2,000, and this should be confirmed in the budget beforehand.

For oligospermia patients traveling to Georgia for IVF, it is medically feasible but requires thorough preparation. It is recommended to complete all necessary tests before departure, bring complete medical records, and communicate the sperm retrieval plan and backup options with the reproductive center in advance. This can minimize uncertainties during the cycle.

Risk Reminder: Known Limitations of ICSI Technology

• ICSI technology itself does not increase the absolute risk of birth defects in offspring, but if the oligospermia patient has a Y-chromosome microdeletion, his male offspring may inherit the same fertility issues.
• When using testicular sperm for ICSI, fertilization and blastocyst formation rates are slightly lower than with ejaculated sperm, but clinical pregnancy rates are not significantly different.
• In ICSI cycles using extremely low sperm concentrations (<0.01 million/ml), the risk of having no transferable embryos is approximately 15-20%.